Literature DB >> 29798662

A Universal GSH-Responsive Nanoplatform for the Delivery of DNA, mRNA, and Cas9/sgRNA Ribonucleoprotein.

Guojun Chen, Ben Ma1, Yuyuan Wang, Shaoqin Gong.   

Abstract

The long-sought promise of gene therapy for the treatment of n class="Species">human diseases remains unfulfilled, largely hindered by the lack of an efficienpan>t and safe delivery vehicle. In this study, we have developed a universal n class="Chemical">glutathione-responsive nanoplatform for the efficient delivery of negatively charged genetic biomacromolecules. The cationic block copolymer, poly(aspartic acid-(2-aminoethyl disulfide)-(4-imidazolecarboxylic acid))-poly(ethylene glycol), bearing imidazole residues and disulfide bonds, can form polyplexes with negatively charged DNA, mRNA, and Cas9/sgRNA ribonucleoprotein (RNP) through electrostatic interactions, which enable efficient cellular uptake, endosomal escape, and cytosol unpacking of the payloads. To facilitate the nuclear transport of DNA and RNP, the nuclear localization signal peptide was integrated into the DNA or RNP polyplexes. All three polyplex systems were fully characterized and optimized in vitro. Their relatively high transfection efficiency and low cytotoxicity, as well as convenient surface functionalization merit further investigation.

Entities:  

Keywords:  gene editing; gene therapy; nonviral vehicle; polyplex; redox-responsive polymer

Mesh:

Substances:

Year:  2018        PMID: 29798662      PMCID: PMC6141193          DOI: 10.1021/acsami.8b03496

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  33 in total

Review 1.  Nuclear entry of nonviral vectors.

Authors:  D A Dean; D D Strong; W E Zimmer
Journal:  Gene Ther       Date:  2005-06       Impact factor: 5.250

2.  CRISPR gene-editing tested in a person for the first time.

Authors:  David Cyranoski
Journal:  Nature       Date:  2016-11-24       Impact factor: 49.962

Review 3.  Non-viral vectors for gene-based therapy.

Authors:  Hao Yin; Rosemary L Kanasty; Ahmed A Eltoukhy; Arturo J Vegas; J Robert Dorkin; Daniel G Anderson
Journal:  Nat Rev Genet       Date:  2014-07-15       Impact factor: 53.242

Review 4.  Polymer gene delivery: overcoming the obstacles.

Authors:  Ahmed Aied; Udo Greiser; Abhay Pandit; Wenxin Wang
Journal:  Drug Discov Today       Date:  2013-07-04       Impact factor: 7.851

5.  In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers.

Authors:  Tyrel T Smith; Sirkka B Stephan; Howell F Moffett; Laura E McKnight; Weihang Ji; Diana Reiman; Emmy Bonagofski; Martin E Wohlfahrt; Smitha P S Pillai; Matthias T Stephan
Journal:  Nat Nanotechnol       Date:  2017-04-17       Impact factor: 39.213

Review 6.  The basic science of gene therapy.

Authors:  R C Mulligan
Journal:  Science       Date:  1993-05-14       Impact factor: 47.728

Review 7.  Gene therapy returns to centre stage.

Authors:  Luigi Naldini
Journal:  Nature       Date:  2015-10-15       Impact factor: 49.962

8.  Long-term effect of gene therapy on Leber's congenital amaurosis.

Authors:  James W B Bainbridge; Manjit S Mehat; Venki Sundaram; Scott J Robbie; Susie E Barker; Caterina Ripamonti; Anastasios Georgiadis; Freya M Mowat; Stuart G Beattie; Peter J Gardner; Kecia L Feathers; Vy A Luong; Suzanne Yzer; Kamaljit Balaggan; Ananth Viswanathan; Thomy J L de Ravel; Ingele Casteels; Graham E Holder; Nick Tyler; Fred W Fitzke; Richard G Weleber; Marko Nardini; Anthony T Moore; Debra A Thompson; Simon M Petersen-Jones; Michel Michaelides; L Ingeborgh van den Born; Andrew Stockman; Alexander J Smith; Gary Rubin; Robin R Ali
Journal:  N Engl J Med       Date:  2015-05-04       Impact factor: 91.245

9.  High content analysis platform for optimization of lipid mediated CRISPR-Cas9 delivery strategies in human cells.

Authors:  Benjamin Steyer; Jared Carlson-Stevermer; Nicolas Angenent-Mari; Andrew Khalil; Ty Harkness; Krishanu Saha
Journal:  Acta Biomater       Date:  2015-12-30       Impact factor: 8.947

10.  CRISPRs for Optimal Targeting: Delivery of CRISPR Components as DNA, RNA, and Protein into Cultured Cells and Single-Cell Embryos.

Authors:  Evguenia Kouranova; Kevin Forbes; Guojun Zhao; Joe Warren; Angela Bartels; Yumei Wu; Xiaoxia Cui
Journal:  Hum Gene Ther       Date:  2016-05-12       Impact factor: 5.695

View more
  11 in total

Review 1.  mRNA-based modalities for infectious disease management.

Authors:  Mengjie Zhang; Abid Hussain; Haiyin Yang; Jinchao Zhang; Xing-Jie Liang; Yuanyu Huang
Journal:  Nano Res       Date:  2022-07-06       Impact factor: 10.269

2.  Disulfide Bridging Strategies in Viral and Nonviral Platforms for Nucleic Acid Delivery.

Authors:  Kingshuk Dutta; Ritam Das; Jewel Medeiros; S Thayumanavan
Journal:  Biochemistry       Date:  2021-01-11       Impact factor: 3.162

Review 3.  External stimuli-responsive nanoparticles for spatially and temporally controlled delivery of CRISPR-Cas genome editors.

Authors:  Ruosen Xie; Yuyuan Wang; Shaoqin Gong
Journal:  Biomater Sci       Date:  2021-09-14       Impact factor: 7.590

Review 4.  Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing.

Authors:  Song Zhang; Jiangtao Shen; Dali Li; Yiyun Cheng
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

Review 5.  Nanomaterials for Protein Delivery in Anticancer Applications.

Authors:  Anne Yau; Jinhyung Lee; Yupeng Chen
Journal:  Pharmaceutics       Date:  2021-01-25       Impact factor: 6.321

Review 6.  Applications and developments of gene therapy drug delivery systems for genetic diseases.

Authors:  Xiuhua Pan; Hanitrarimalala Veroniaina; Nan Su; Kang Sha; Fenglin Jiang; Zhenghong Wu; Xiaole Qi
Journal:  Asian J Pharm Sci       Date:  2021-06-27       Impact factor: 6.598

7.  Polymeric Micelles with pH-Responsive Cross-Linked Core Enhance In Vivo mRNA Delivery.

Authors:  Wenqian Yang; Pengwen Chen; Eger Boonstra; Taehun Hong; Horacio Cabral
Journal:  Pharmaceutics       Date:  2022-06-06       Impact factor: 6.525

Review 8.  Engineering Nanoparticles for Targeted Delivery of Nucleic Acid Therapeutics in Tumor.

Authors:  Yao Xiao; Kun Shi; Ying Qu; Bingyang Chu; Zhiyong Qian
Journal:  Mol Ther Methods Clin Dev       Date:  2018-09-22       Impact factor: 6.698

9.  Microenvironment Activatable Nanoprodrug Based on Gripper-like Cyclic Phenylboronic Acid to Precisely and Effectively Alleviate Drug-induced Hepatitis.

Authors:  Qixiong Zhang; Shanshan Li; Lulu Cai; Yuxuan Zhu; Xingmei Duan; Peidu Jiang; Lei Zhong; Kun Guo; Rongsheng Tong
Journal:  Theranostics       Date:  2021-07-13       Impact factor: 11.600

10.  Location of a single histidine within peptide carriers increases mRNA delivery.

Authors:  Jiaxi He; Songhui Xu; Qixin Leng; A James Mixson
Journal:  J Gene Med       Date:  2020-12-21       Impact factor: 4.565

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.